Effects of clopidogrel therapy on whole blood platelet aggregation, the Plateletworks® assay and coagulation parameters in cats with asymptomatic hypertrophic cardiomyopathy: a pilot study

Autor: den Toom, M L, van Leeuwen, M W, Szatmári, V, Teske, E, Sub Cardiologie, Universitair Veterinair Diagnostisch Lab, Sub Oncologie/Cytologie, dCSCA AVR

Publikováno v: Veterinary Quarterly, 37(1), 8. Koninklijke Nederlandse Maatschappij voor Diergeneeskunde
Veterinary Quarterly, Vol 37, Iss 1, Pp 8-15 (2017)

BACKGROUND: Although scientific evidence is limited, clopidogrel is frequently used as prophylaxis for arterial thromboembolism in cats with hypertrophic cardiomyopathy (HCM). OBJECTIVES: Evaluating effects of clopidogrel therapy in asymptomatic cats

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd60f82a4a22639ebeb1ad6ebac63b05
https://doi.org/10.1080/01652176.2016.1244618

Effects of clopidogrel therapy on whole blood platelet aggregation, the Plateletworks® assay and coagulation parameters in cats with asymptomatic hypertrophic cardiomyopathy: a pilot study.

Autor: den Toom, M. L., van Leeuwen, M. W., Szatmári, V., Teske, E.

Publikováno v: Veterinary Quarterly; 2017, Vol. 37 Issue 1, p8-15, 8p